In NAFLD patients, total fecal BA concentrations are generally elevated, whereas suppression of bacterial BSH activity by its inhibitor caffeic acid phenethyl ester can alleviate NAFLD through inhibiting intestinal FXR signaling (Zhong et al., 2023). Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.